Benzodiazepines
Medically reviewed by the Shrinkopedia editorial team, led by Shariq Refai, MD, MBA, FAPA.
7 min read · 1,684 words
- Medically reviewed . Reviewed by a board-certified psychiatrist before publication.
- Sourced from primary literature . DSM-5-TR, NICE, the American Psychiatric Association, the NIMH, Cochrane, peer-reviewed research.
- Dated and kept current . Every entry shows when it was published, reviewed, and last updated.
- Honest about uncertainty . Each entry carries an evidence-strength rating and a "what we know and what we don't" section.
- Independent . No advertising, no affiliate revenue, no sponsored content.
Benzodiazepines are a class of medications that act quickly to reduce anxiety and calm the nervous system. Some are also used for sleep, seizures, and other purposes. They're effective and genuinely useful in specific, usually short-term situations. But with regular use they carry real risks of tolerance and dependence, so current guidelines generally recommend them for short-term or occasional use rather than as a long-term treatment for chronic anxiety.
Prefer the quick definition? Read this term on Shrinktionary →
Definition
Benzodiazepines are a family of medications that calm the nervous system, often within minutes to an hour. Common examples include alprazolam, lorazepam, clonazepam, and diazepam. They're used mainly for anxiety and panic, and some are also used for sleep, seizures, alcohol withdrawal, and other purposes.
They work by enhancing the effect of GABA, the brain's main calming neurotransmitter, which dampens overactivity in the nervous system. This entry is an overview. It doesn't cover drug-by-drug detail or dosing, which belong with a prescriber and with PsychiatryRx.org.
### Common benzodiazepines at a glance
| Benzodiazepine | Brand | Onset | Half-life | Key clinical use |
|---|---|---|---|---|
| alprazolam | Xanax | fast (30-60 min) | short (6-27 hr) | high abuse potential; strong interdose withdrawal; avoid when possible |
| lorazepam | Ativan | intermediate | intermediate (10-20 hr) | no active metabolites; safer in liver disease and elderly |
| clonazepam | Klonopin | intermediate | long (20-50 hr) | steady levels; often used for panic disorder and seizure adjunct |
| diazepam | Valium | fast | long (20-100 hr with active metabolites) | strong muscle relaxant; useful for alcohol withdrawal taper |
| temazepam | Restoril | intermediate | intermediate (8-20 hr) | primarily a sleep-onset agent |
| midazolam | Versed | very fast | very short (1-4 hr) | procedural/anesthetic use, not for outpatient anxiety |
What it looks like
- A prescriber offers a short course or an as-needed supply for a defined, specific situation.
- A person takes one for an intense panic episode and feels the edge come off fairly quickly.
- A clinician keeps the use brief and revisits the plan rather than letting it run open-ended.
- Someone who's been taking one regularly works out a slow, planned taper with their prescriber.
- The longer-term plan leans on therapy and other medication, with benzodiazepines as a limited tool.
What people often confuse this with
A first-line, long-term anxiety treatment. For chronic anxiety, current guidelines point to therapy such as CBT and antidepressants such as SSRIs and SNRIs as first-line. Benzodiazepines are better understood as a short-term or occasional tool, not the foundation of long-term anxiety care.
An addictive substance with no legitimate use. Benzodiazepines have a real risk of dependence and misuse, and that deserves respect. But they're also genuinely effective and appropriate in specific situations. Both things are true. The point is careful, considered use, not avoidance or alarm.
Interchangeable with antidepressants for anxiety. SSRIs and SNRIs treat anxiety over weeks and are suited to ongoing use. Benzodiazepines work in minutes and are suited to short-term relief. They're different tools with different roles, and they're sometimes used together early in treatment.
Reality check
Myth: Benzodiazepines are just dangerous and should never be used.
Benzodiazepines are effective and fast-acting for acute anxiety and panic, which makes them genuinely useful in specific, usually short-term situations. The risks are real, but so is the benefit. The honest position is a useful tool used carefully, with decisions belonging to a prescriber.
Myth: Needing to taper means a person was misusing the medication.
Physical dependence can develop with regular, prescribed use exactly as directed. It isn't the same as misuse or addiction. It means the body has adapted, which is why stopping or reducing after sustained use should be done by tapering with a prescriber. Abrupt withdrawal can be dangerous.
Myth: If a low dose works, it'll keep working at that dose forever.
With regular use, tolerance often develops, so the same dose gradually does less. That's part of why long-term daily use for chronic anxiety is generally discouraged, and why these medications are best matched to short-term or occasional needs.
What research says
The evidence base for benzodiazepines is strong, and it supports a balanced picture. They're effective and fast-acting for acute anxiety and panic. They also carry well-documented risks: tolerance, physical dependence, a withdrawal syndrome that needs careful tapering, and effects on memory and coordination. They carry particular risks in older adults, where they raise the chance of falls and confusion, and when combined with alcohol or opioids, where the combination can dangerously suppress breathing.
For these reasons, clinical guidelines generally recommend benzodiazepines for short-term or occasional use rather than as a long-term treatment for chronic anxiety. For ongoing anxiety, therapy such as CBT and antidepressants such as SSRIs and SNRIs are first-line. Benzodiazepines remain a valuable option for specific, time-limited situations, used carefully and reviewed regularly.
What we know and what we don't know
What we know
- Benzodiazepines are effective and fast-acting for acute anxiety and panic.
- Regular use leads to tolerance and physical dependence, and stopping after sustained use needs a planned taper.
- Guidelines favor short-term or occasional use, with therapy and antidepressants first-line for chronic anxiety.
What we don't know
- The best way to predict who will struggle most with tolerance or withdrawal isn't fully worked out.
- The long-term effects of extended use, including questions about thinking and memory, are still studied and debated.
- The ideal pace and approach for tapering varies between people and isn't fully standardized.
Questions people ask
Are benzodiazepines safe for daily use?
Short courses (weeks) are generally safe for most people. Daily use for months or years carries real risks: tolerance, physical dependence, cognitive effects, falls in older adults, and difficult withdrawal. Recent guidance strongly favors short-term use rather than long-term use.
How long is safe?
There isn't a hard cutoff. Two to four weeks is a common target for acute anxiety, panic, or sleep. Some clinical situations warrant longer use. The pattern to avoid is chronic use without a clear plan, which is where most of the trouble develops.
What's the withdrawal like?
Depends on the medication, the dose, and the duration. Short courses at low doses can often be stopped without symptoms. Long courses at higher doses can produce a withdrawal syndrome (anxiety, insomnia, tremor, seizure in severe cases) that requires a slow, medically supervised taper. Stopping suddenly after long-term use can be dangerous.
Are they addictive?
They can be. Physical dependence develops with regular use over weeks to months. Psychological dependence and abuse are more common in some people than others, particularly those with substance use histories. Not everyone who takes them for a legitimate reason develops a problem, but the risk is real.
What are the alternatives?
For anxiety, SSRIs and SNRIs are first-line for long-term treatment. Buspirone can help. Cognitive behavioral therapy has strong evidence and doesn't carry the same risks. Beta blockers help specific performance-related anxiety. For sleep, CBT for insomnia is first-line.
How it works
What's useful to understand about benzodiazepines:
- they boost the effect of GABA, a neurotransmitter that calms the nervous system (you can watch what a benzodiazepine does at the GABA receptor in PsychiatryRx's interactive guide)
- the effect is fast, often felt within minutes to about an hour
- that speed makes them effective for acute anxiety, panic, and short-term relief
- with regular use, the body develops tolerance, so the same dose does less over time
- regular use also leads to physical dependence, which is a normal physiological response, not a moral failing
- stopping after sustained use needs a gradual taper guided by a prescriber
Medications in this class
Class receptor mechanism. Positive allosteric modulators at GABA-A receptors (α1, α2, α3, α5 subunits) that enhance chloride conductance, increasing GABAergic inhibition. α1 → sedation/amnesia; α2/α3 → anxiolysis; α5 → cognitive/motor effects.
Class safety monitoring. Dependence and tolerance (avoid > 2-4 week continuous use for most anxiety/insomnia indications), sedation, respiratory depression (especially with opioids, an FDA boxed warning), falls in elderly (STOPP/START and Beers Criteria caution), driving impairment, paradoxical disinhibition, memory impairment, misuse potential, withdrawal risk (seizures possible with abrupt discontinuation of high-dose long-term use). Taper 10-25% per 1-2 weeks. Avoid in pregnancy where possible.
| Drug | Half-life | Onset | Typical adult dose | Notes |
|---|---|---|---|---|
| Diazepam | 20-100 h (with metabolites) | Fast (PO) | 2-10 mg 2-4x/day; alcohol withdrawal higher | Long-acting; self-tapering; hepatically metabolized |
| Lorazepam | 10-20 h | Intermediate | 0.5-2 mg 2-3x/day (max 10 mg/day) | No active metabolites; glucuronidated (safer in liver disease); IM/IV usable |
| Alprazolam | 6-12 h | Fast | 0.25-0.5 mg TID (max 4 mg/day, panic to 10 mg/day) | Highest misuse liability; severe interdose rebound and discontinuation |
| Clonazepam | 20-50 h | Intermediate | 0.25-0.5 mg BID (up to 4 mg/day, panic; 20 mg/day, seizures) | Long half-life aids smoother course |
| Temazepam | 8-15 h | Slow | 7.5-30 mg qHS for insomnia | Glucuronidated; preferred for elderly with insomnia when a BZD is used |
| Oxazepam | 4-15 h | Slow | 10-30 mg 3-4x/day | Glucuronidated; hepatic-friendly |
| Chlordiazepoxide | 6-25 h (metabolites longer) | Slow | 25-100 mg 4x/day for alcohol withdrawal (CIWA-triggered) | Long history in alcohol withdrawal |
| Midazolam | 1.5-3 h | Very fast (IV) | Procedural sedation; not for chronic outpatient use | Short-acting; anesthesia and status epilepticus |
Sources. FDA labels; ASAM 2020 Alcohol Withdrawal Management Guideline; Beers Criteria 2023; NICE NG215 (medicines associated with dependence).
- Pregnancy and breastfeeding. Every entry should link to condition-specific perinatal considerations and reference LactMed/NICE/APA perinatal guidance.
- Drug interactions. SSRIs/SNRIs + MAOIs (14-day washout, 5 weeks for fluoxetine); lithium + NSAIDs/ACEi/thiazides; carbamazepine broad CYP induction; clozapine + fluvoxamine, ciprofloxacin.
- Discontinuation. Taper SSRIs, SNRIs, benzodiazepines, and antipsychotics gradually. Fastest tapers (paroxetine, venlafaxine, short-acting benzos) carry the most discontinuation symptoms.
- Metabolic monitoring standard. Per the ADA/APA consensus, still the standard framework in 2026: baseline, 4, 8, 12 weeks, then quarterly: weight/BMI, waist. Baseline, 3 months, then annually: fasting glucose or HbA1c, fasting lipids, BP.
- QTc considerations. Baseline ECG for citalopram > 20 mg (age > 60), ziprasidone, IV haloperidol, thioridazine, and any combination of QT-prolonging agents.
Sources
- U.S. Food and Drug Administration (FDA). Benzodiazepine labeling and safety communications.
- National Institute for Health and Care Excellence (NICE). Guidance on anxiety disorders and benzodiazepine use.
- American Psychiatric Association (APA). Practice guidance on anxiety and panic disorders.
- National Institute of Mental Health (NIMH). Mental Health Medications overview.
- FDA prescribing information (label) for each drug, accessed via DailyMed.
- APA Practice Guidelines (Schizophrenia 3rd ed.; MDD; Bipolar Disorder; OCD).
- NICE Guidelines: NG222 (Depression 2022), CG185 (Bipolar 2014, updated), CG178 (Psychosis and schizophrenia 2014, updated), NG215 (Medicines associated with dependence).
- ADA/APA Consensus on Antipsychotic Drugs and Obesity/Diabetes (2004, still foundational; updates via ISBD/EPA metabolic monitoring statements).
- Carolan A, et al. Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation. Schizophrenia Bulletin. 2025;51(5):1193-1203.
- FDA Drug Safety Communication: Clozapine REMS elimination (February 24, 2025).
- AAPP Clozapine in Practice guideline (2025 updates).
- International Society for Bipolar Disorders (ISBD) lithium and mood-stabilizer consensus statements.
- APA/ASKP Consensus on Ketamine and Esketamine (2017 base; 2023-2025 updates).
- Beers Criteria (AGS 2023) and STOPP/START v3 (2023) for prescribing in older adults.
- Cochrane systematic reviews for individual class efficacy and safety.
Read how Shrinkopedia builds and reviews its content.
How to cite this page
- Short
Benzodiazepines. Shrinkopedia, medically reviewed by Shariq Refai, MD, MBA. https://shrinkopedia.com/treatments/benzodiazepines/- APA
Shrinkopedia. (2026, June 8). Benzodiazepines. Medically reviewed by Shariq Refai, MD, MBA. https://shrinkopedia.com/treatments/benzodiazepines/- MLA
"Benzodiazepines." Shrinkopedia, 8 June 2026, https://shrinkopedia.com/treatments/benzodiazepines/.
Click a citation to select it.
Medical disclaimer
Shrinkopedia is for education, not medical advice. It can't tell you whether a benzodiazepine is right for you, and it isn't a substitute for care from a licensed clinician. Starting, changing, or stopping one of these medications should always be done with a prescriber, since stopping abruptly after regular use can be dangerous.
If you're in crisis or thinking about harming yourself, call or text 988 in the US to reach the Suicide and Crisis Lifeline, or call 911.
See where this fits in the Atlas: how your mind works →
Walk the connection from this entry outward.
- 1 TREATMENT Benzodiazepines (current)
The Knowledge Path is a curated walk. Every step is one decision away from the next.
You are here: Shrinkopedia, the concept layer of The Shrink Network.
Understand the idea here first, then follow it to the property that takes it further.
Read a related treatment →Want to understand more first?
- Understand anxiety at AnxietyResource →
- Work with the pattern at shrinQ →
- Consider clinical evaluation at shrinkMD →
Disclosure: shrinkMD is the clinical care practice within The Shrink Network, the same network that publishes Shrinkopedia. Shrinkopedia takes no referral or affiliate commission for care.